Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Importance of Content Validity in Accredited Continuing Medical Education/Continuing Professional Development (CME/CPD).

Journal of CME·2026
Same author

Publisher Correction: Twelve month refractive and axial length changes in the Israeli refractive error, activity, and devices (iREAD) study.

Scientific reports·2025
Same author

Mitigating Gambling-Related Harms in Children and Young People: A Scoping Review of Interventions.

Journal of gambling studies·2025
Same author

Twelve month refractive and axial length changes in the Israeli refractive error, activity, and devices (iREAD) study.

Scientific reports·2025
Same author

Therapeutic Whole Lung Lavage for Pulmonary Alveolar Proteinosis: Technique With Continuous Video-Enabled Double Lumen Endotracheal Tube.

Respirology case reports·2025
Same author

Effect of COVID-19 on Continuing Education Activities and Learner Interactions: Report from Six Accreditation Systems.

Journal of CME·2024

Related Experiment Video

Updated: May 17, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Levothyroxine and prednisone causing generalized weakness in a middle-aged man.

Andrew Word1, Kevin Davidson, Essam Elsayed

  • 1Departement of Internal Medicine, UT Southwestern Medical School, 5323 Harry Hines Blvd., Dallas, TX 75390, USA.

Case Reports in Endocrinology
|November 3, 2012
PubMed
Summary

Thyrotoxic periodic paralysis, a rare condition, causes sudden weakness and low potassium. This case highlights its occurrence in a middle-aged Hispanic male after medication changes, emphasizing prompt diagnosis.

Related Experiment Videos

Last Updated: May 17, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Area of Science:

  • Endocrinology
  • Neurology
  • Genetics

Background:

  • Thyrotoxic periodic paralysis (TPP) is a rare disorder linked to hyperthyroidism.
  • It predominantly affects middle-aged men of Asian and Hispanic descent.
  • TPP can manifest as episodes of profound muscle weakness and hypokalemia.

Purpose of the Study:

  • To describe a case of TPP in a previously asymptomatic middle-aged Hispanic male.
  • To review the clinical presentation, underlying mechanisms, and treatment strategies for TPP.
  • To underscore the importance of considering TPP in patients presenting with hypokalemia.

Main Methods:

  • Case report of a middle-aged Hispanic male with generalized weakness and hypokalemia.
  • Review of clinical findings, laboratory results, and treatment course.
  • Literature review on the pathophysiology and management of TPP.

Main Results:

  • The patient presented with severe hypokalemia and muscle weakness following changes in levothyroxine and initiation of prednisone.
  • Thyrotoxicosis was identified as the underlying cause of the hypokalemic periodic paralysis.
  • Treatment involved addressing the thyrotoxicosis and managing potassium levels.

Conclusions:

  • TPP is a critical diagnosis to consider in patients with unexplained hypokalemia and muscle weakness, especially those with risk factors.
  • Prompt identification and management of thyrotoxicosis are essential for preventing recurrent paralysis episodes.
  • This case underscores the variability in TPP presentation and the importance of a thorough medical history.